Rick E Winningham
2013 - Theravance Biopharma
In 2013, Rick E Winningham earned a total compensation of $1.7M as Chief Executive Officer at Theravance Biopharma.
Compensation breakdown
| Bonus | $129,004 |
|---|---|
| Non-Equity Incentive Plan | $516,016 |
| Salary | $857,940 |
| Stock Awards | $244,420 |
| Other | $500 |
| Total | $1,747,880 |
Winningham received $857.9K in salary, accounting for 49% of the total pay in 2013.
Winningham also received $129K in bonus, $516K in non-equity incentive plan, $244.4K in stock awards and $500 in other compensation.
Rankings
In 2013, Rick E Winningham's compensation ranked 4,349th out of 12,286 executives tracked by ExecPay. In other words, Winningham earned more than 64.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,349 out of 12,286 | 65th |
Division Manufacturing | 1,489 out of 4,612 | 68th |
Major group Chemicals And Allied Products | 422 out of 1,462 | 71st |
Industry group Drugs | 289 out of 1,156 | 75th |
Industry Pharmaceutical Preparations | 232 out of 890 | 74th |
Source: SEC filing on March 17, 2015.
Winningham's colleagues
We found one more compensation record of an executive who worked with Rick E Winningham at Theravance Biopharma in 2013.
2013
Bradford Shafer
Theravance Biopharma
General Counsel
News
Theravance Biopharma CEO Rick Winningham's 2023 pay falls 31% to $4.3M
April 5, 2024
Theravance Biopharma CEO Rick Winningham's 2020 pay rises 11% to $6.6M
March 22, 2021
Theravance Biopharma CEO Rick Winningham's 2019 pay jumps 135% to $5.9M
March 24, 2020
Theravance Biopharma Former Senior Vice President, Corporate Development and Strategy Shehnaaz Suliman's 2018 pay falls 35% to $2.7M
March 20, 2019